| Thu, Jul 9, 2009 | | | Where You'll Find Today's Best Value Stocks at Motley Fool (Thu 3:36pm)
| | Sun, Jul 5, 2009 | | | Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis Business Wire (Sun, Jul 5)
| | Thu, Jul 2, 2009 | | | [$$] Completing a Market Top at RealMoney by TheStreet.com (Thu, Jul 2)
| | | Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction Business Wire (Thu, Jul 2)
| | Wed, Jul 1, 2009 | | | Alcon Inc. Earnings Call scheduled for Thu, July 23 CCBN (Wed, Jul 1)
| | | Alcon Announces Second Quarter 2009 Financial Release and Conference Call Dates Business Wire (Wed, Jul 1)
| | Mon, Jun 29, 2009 | | | Another Day, Another Rumored Suitor at Motley Fool (Mon, Jun 29)
| | | 20% Dividend Yields? Oh, Yeah? at Motley Fool (Mon, Jun 29)
| | | UPDATE - Nestle restates 2009 guidance, sees better H2 at Reuters (Mon, Jun 29)
| | Fri, Jun 26, 2009 | | | UPDATE - Ista wins U.S. panel support for eye itch drug at Reuters (Fri, Jun 26)
| | | US panel rejects River Plate, Alcon dry eye drug at Reuters (Fri, Jun 26)
| | Thu, Jun 25, 2009 | | | wRatings and UTEK Corporation's Strategos Identify Most Competitive Health Care Companies Business Wire (Thu, Jun 25)
| | Wed, Jun 24, 2009 | | | UPDATE - US FDA staff: No big safety issues with Ista drug at Reuters (Wed, Jun 24)
| | | UPDATE - US FDA staff: Problems in River Plate drug studies at Reuters (Wed, Jun 24)
| | Tue, Jun 23, 2009 | | | Look Beyond the Usual Suspects for Profits at Motley Fool (Tue, Jun 23)
| | | Alcon's Growth Stymied By the Economy at Seeking Alpha (Tue, Jun 23)
| | Mon, Jun 22, 2009 | | | Alcon Growth Stymied by Economy Zacks.com (Mon, Jun 22)
| | | 5 Top Stocks at Half Price at Motley Fool (Mon, Jun 22)
| | Thu, Jun 18, 2009 | | | Alcon walkathon aims to prevent blindness at bizjournals.com (Thu, Jun 18)
| | Mon, Jun 15, 2009 | | | [$$] Alcon Deal Puts Novartis in a Bind at The Wall Street Journal Online (Mon, Jun 15)
| Add ACL News to My Yahoo!:

| |
|